REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 134 filers reported holding REPLIMUNE GROUP INC in Q3 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $614,163 | -39.9% | 35,895 | -18.4% | 0.00% | 0.0% |
| Q2 2023 | $1,021,704 | +76.8% | 44,001 | +34.5% | 0.00% | 0.0% |
| Q1 2023 | $577,853 | -20.8% | 32,721 | +21.9% | 0.00% | 0.0% |
| Q4 2022 | $729,830 | +119.2% | 26,832 | +39.5% | 0.00% | – |
| Q3 2022 | $333,000 | +13.3% | 19,237 | +14.0% | 0.00% | – |
| Q2 2022 | $294,000 | +5.8% | 16,873 | +3.0% | 0.00% | – |
| Q1 2022 | $278,000 | -35.8% | 16,382 | +2.5% | 0.00% | – |
| Q4 2021 | $433,000 | -2.7% | 15,983 | +6.6% | 0.00% | – |
| Q3 2021 | $445,000 | -18.6% | 14,994 | +5.2% | 0.00% | – |
| Q2 2021 | $547,000 | -7.3% | 14,250 | -26.4% | 0.00% | – |
| Q1 2021 | $590,000 | -69.1% | 19,354 | -61.3% | 0.00% | -100.0% |
| Q4 2020 | $1,907,000 | +688.0% | 49,999 | +375.1% | 0.00% | – |
| Q3 2020 | $242,000 | -50.3% | 10,524 | -78.5% | 0.00% | – |
| Q1 2020 | $487,000 | – | 48,924 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 5,344,971 | $122,395,000 | 33.11% |
| Corriente Advisors, LLC | 512,500 | $11,798,000 | 5.98% |
| Bain Capital Life Sciences Investors, LLC | 2,122,415 | $48,858,000 | 4.55% |
| BVF INC/IL | 1,691,834 | $38,946,000 | 2.12% |
| Redmile Group, LLC | 3,330,999 | $76,680,000 | 1.41% |
| EMERALD ADVISERS, LLC | 891,761 | $20,528,000 | 0.84% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 823,989 | $18,968,000 | 0.84% |
| Penn Mutual Asset Management, LLC | 15,877 | $365,000 | 0.52% |
| EAM Global Investors LLC | 54,274 | $1,249,000 | 0.46% |
| Artal Group S.A. | 700,000 | $16,114,000 | 0.39% |